STRATEGIC MARKETING PLAN

SIEMENS HEALTHINEERS

Course Title: BUS541 Marketing

Lectuter:Mehmet Baskn YENICIOGLU
Istanbul Bilgi University

Mehmet Atalay Yenibertiz

115604069

1
 TABLE OF CONTENT
Executive Summary3
1) Company and Market. 3
1.1) Siemens Healthineers.. 3
1.2) Current Situation of Market and Market Data.3
1.2.1)Global Condition. 3
1.2.2)In Turkey.5
1.3)SWOT Analysis.. 10
1.4)PESTEL Analysis. 11
1.5)PEST Analysis of Domestic Medical Device Market. 11
1.6)Competitors.. 13
1.7)Customer Analysis. 13
2) Marketing Strategy.. 14
2.1)Segmentation and Targeting.. 14
2.1.1)Segmentation.. 14
2.1.2)Targeting.. 16
2.2)Positioning Statements. 16
3) Marketing Tactics.. 17
3.1)Marketing Mix 17
3.1.1)Product.... 17
3.1.1.1)Existing Product... 19
3.1.1.2)New Product.. 19
3.1.2)Price.. 19
3.1.3)Place. 20
3.1.4)Promotion.. 20
3.1.4.1) Promotion For Existing Products 20
3.1.4.2) Promotion For New Products 21
4) Appendices.. 21
5) References. 24

2
Executive Summary

What does a marketing department do? This course is very helpful to able to describe the philosophy
and task of marketing deparment. In that study I tried to incorporate all the information and data we
have learned during this lecture.

This project is prepared on the basis of a multinational company which is Siemens Healthineers
Medical Imaging. I have been working more than 8 years in Medical Imaging area.

In this project, the first part discusses company, current market data at global and national, SWOT
analysis, PESTEL analysis, PEST analysis of Turkish medical device industry, Competitors and Customer
analysis. Second part, about segmentation of medical imaging devices and targeting of the company
and positioning statement of the company. And the third part discusses marketing mix. Additionally,
there is a reference part which includes all related references.

1. Company and Market

1.1 Siemens Healthineers

Siemens Healthineers (formerly Siemens Healthcare, Siemens Medical Solutions, Siemens Medical
Systems) is a medical technology company and is headquartered in Erlangen, Germany. The
company dates its early beginnings in 1847 to a small family business in Berlin, co-founded by Ernst
Werner von Siemens. Siemens Healthineers is connected to the larger corporation, Siemens AG. The
name Siemens Medical Solutions was adopted in 2001, and the change to Siemens Healthcare was
made in 2008. In 2015, Siemens named Bernd Montag as its new global CEO. In May 2016, Siemens
Healthcare was renamed "Siemens Healthineers." Globally the company has 45,000 employees, most
of them in Germany.

1.2 Current Situation of Market and Market Data:

1.2.1 Global Condition:

Molecular imaging market has grown manifold during the course of time, primarily due to increasing
demand for detection and monitoring of disease such as cancer and other rare genetic disorders.
Molecular imaging is one such technique which has helped to understand the disease complexities
in a more efficient manner.
Molecular imaging is a biomedical discipline that provides detailed visualizations and measurement
of biologic processes taking place inside the body at molecular, cellular and genetic level. The prime
function of molecular imaging is to interrogate biological processes in the cells of the humans or
other living organisms to understand the abnormalities and malfunctioning that cause or form the
basis of disorders.
Various techniques that have been used in molecular imaging includes Magnetic Resonance
Imaging (MRI), Magnetic Resonance Spectroscopy (MRS), X-ray Computed Tomography (CT),
ultrasound, optical imaging, single photon emission computed tomography (SPECT) and several
others. Amongst all other techniques photon emission tomography (PET) especially SPCET are most
commonly used techniques due to their ability to allow interrogation at detailed tissue depths. PET
and SPCET scanners generate images of lungs, livers, and hearts and also provide information about
the organs metabolism and other functions.
Substantial increase in demand for molecular imaging has been reported across the globe. Moreover,
developed markets registered highest growth; these markets also represents the largest pie in the
global molecular imaging services and devices market. Currently, US tops the global demand for
molecular imaging services as well as devices, if countries taken into consideration. In 2013 US
accounted for around one half of the global molecular imaging services and devices market.
Molecular imaging helps to detect the illness or disease at the earlier stage and is proved to be very
effective to analyze the cardiovascular disease conditions, neurological conditions and cancer stages.

3
Imaging systems enable medical professionals to make processes within the human body visible so
that they can diagnose pathological changes and precisely target therapeutic procedures. According
to market experts, such imaging methods have substantial growth potential. For example, an analysis
conducted by Research and Markets in 2016 forecasts that the market for medical imaging systems
will grow from $30.2 billion in 2013 to $94 billion in 2016. To date, the associated market revenue
has been mainly concentrated in industrialized countries and generated by a few international
corporations. The market experts from Frost & Sullivan state that GE, Philips and Siemens accounted
for 78 percent of the global market revenue from medical imaging equipment in 2016.

4
1.2.2 In Turkey

There are about 2 thousand 350 high tech medical imaging devices ( MRI, CT, PET/CT) in Turkey.
High tech medical imaging devices number of every one million people is just 28. Turkey has no high
tech imaging devices in many provinces.

High Tech Medical Devices Number per 1 million people in Turkey

Computed Tomography (CT) 15
Magnetic Resonance Imaging (MRI) 14,3
Positron Emission Tomography/Computed Tomography (PET/CT) 1,2
Linear Accelerator (LINAC) 2,3

In 2009, Siemens established a new 76 million $ valued manufacturing site in Gebze Organized
Industry Area.Turkey has more than 6 thousand Siemens high tech medical imaging devices, and
200 thousand patient treat by these devices every day.

PET/CT MRI CT

37% 27%
35%
65% 63% 73%

SIEMENS OTHERS SIEMENS OTHERS SIEMENS OTHERS

5
 Computed Tomography (CT)
Device Distribution

Devices Number per 1 million People First 20 City Aggregate Devices Number First 20 City

Average of Turkey Total of First 20 City : 754 (73%)

Total of Turkey : 1035 (100%)

Computed Tomography (CT)

Device Distribution

Devices Number per 1 million People Turkey Distribution

Average of Turkey : 15 / one million people

above the average below the average

6
 Computed Tomography (CT)
Europe Average Comparison

Device/1 milion people

Magnetic Resonance Imaging (MRI)

Device Distribution

Devices Number per 1 million People First 20 City Aggregate Devices Number First 20 City

Total of First 20 City : 789 (76%)

Total of Turkey : 1038 (100%)

7
 Magnetic Resonance Imaging (MRI)
Device Distribution

Devices Number per 1 million People Turkey Distribution

Average of Turkey : 14,3 / one million people

above the average below the average

Computed Tomography (CT)

Europe Average Comparison

Device/1 milion people

8
 Positron Emission Tomography/Computed Tomography (PET/CT)
Device Distribution

Devices Number per 1 million People First 20 City Aggregate Devices Number First 20 City

Total of Turkey : 267

Positron Emission Tomography/Computed Tomography (PET/CT)

Device Distribution

Devices Number per 1 million People Turkey Distribution

Average of Turkey : 1,2 / one million people

above the average below the average it doesn't exist

9
 Positron Emission Tomography/Computed Tomography (PET/CT)
Device Distribution

Device/1 milion people

1.3 SWOT Analysis

This SWOT Analysis of Siemens Healthineers, Inc. provides a strategic SWOT analysis of the company's
businesses and operations.

Strengths
-experienced business units
-barriers of market entry
-reduced labour costs
-existing distribution and sales networks
-high profitability and revenue
-high growth rate

Weaknesses
-brand portfolio
-investments in research and development
-competitive market
-cost structure
Opportunities
-growth rates and profitability
-new products and services
-venture capital

Threats
-rising cost of raw materials
-increasing costs
-tax changes
-government regulations
-cash flow
-financial capacity
10
 1.4 Pestel Analysis:

Political Factors
Siemens Healthineers does not franchise or spread the company in regions that are in war time, thus
you would not find Siemens Healthineers serving in Pakistan, Syria, etc. and Iran because of political
embargo on Iran.

Economical factors
As the economic crisis is still running into many countries, Siemens Healthineers can be less
demanded by customers into poor regions like Egypt, India, etc. Thus the company's main target
markets nowadays are the Americas, Europe, and the Middle East.

Social Factors
Siemens Healthineers is perceived by customers as a stable, powerful company with good reputation.

Technological factors
The company is always up to date with new solutions, ideas, and devices to beat the competition
with technology on the way of saving lives.

Environmental factors
Differs from a country to another, depending on the economy, culture, and people. In some countries
like Egypt, the environment is not always stable as the economy is not.

Legal factors
Siemens Healthineers is the kind of company that can hardly be put into judging court for copying
rights or stealing ideas. Siemens Healthineers legal history is very clean, and the company always
avoids troubles and courts. Siemens Healthineers primary goal is to establish a high end network of
qualified employees who know exactly how to gain the biggest market share.

1.5 PEST Analysis of Turkish Medical Device Market

Political, legal, and regulatory environment
The Turkish government started Health Transformation Program in 2003 and vision 2023 are both
mapping Medical Device Sector. Current government liberal policies offer the sector opportunities.
The medical device products that we plan to launch have to be approved by the appropriate bodies
according to the TURKISH MEDICINES AND MEDICAL DEVICES AGENCY (TMMDA) under control of
Minister of Health. The conditions can differ depending on the type of a device. Mostly the CE mark
is needed to be able to sell the device in Turkey. It is the task company to successfully complete the
process of gaining the CE mark, without the CE mark, no medical devices can be sold. For the launch
of any medical device, medical devices directives should be followed.
All of service engineers should have achievement certificate on the training depending on directives
of Ministry of Labour and Social Security.

Economic/Demographic environment
The Turkish economy has shown good performance with its steady growth in 2002-2013. A sound
macroeconomic strategy in combination with prudent fiscal policies and major structural reforms in
effect since 2002 has integrated the Turkish economy into the globalized world, while transforming
the country into one of the major recipients of FDI in its region. And then last two years, Statistics from
the International Monetary Fund show that Turkish economic growth looks set to become
worsening. Statistics show that long-term threats to the Turkish economy come less from the
November 24, 2015 Russian warplane incident and recent terroristic bombing and attacks.

11
 Social and Cultural environment
Medical devices are not being sold to the end users but to the doctors and the management of
hospitals. Generally, the end users (patients) do not care about the medical devices as such that are
used to diagnose and treatment. Very few patient are surfing on Web to see what kind of machines
be over the world. They are focused on being healthy again, regardless of the brand of the medical
device used. For this reason, the values and beliefs of the end users are not for the marketing strategy
as relevant as the physicians beliefs. Therefore, it is more important to know the physicians and to be
in contact with the management of the hospital. This is the task of the sales representatives in Turkey.
They have to know the physicians, their beliefs and values in order to impress them with the offering.
Company should be perceived by customers as a stable, powerful company with good reputation.

Technological, Competitive and Infrastructure Environment

Medical devices market is a very competitive market and contains only a few strong players. All
medical devices producers are investing large amounts of money in research, development and
innovations. In this market, the company who brings the innovative technology the first, usually wins
or has a considerable competitive advantage.

Macro environment Opportunities Threats

Political, Legal Health Transformation Program Russian aircraft incident
Vision 2023 Terrorism
Liberal Policies

Economic/Demographic Increase GDP Exchange Rate fluctuations

The Medical device industry is
only moderately impacted by
the economic crisis
Medical Device Market is a
growing market

Social and Cultural
End customers are not familiar
or loyal to brands, good
personal relationships with
doctors and hospitals will help
the gain of market share and
sales
Dependency on personal
relationships with doctors and
hospitals can provide a risk
when relationship deteriorates

Technological To have strong reputation Competitive market new

concerning High Tech devices Innovative Technologies by
and innovative products competitors can provide a risk
and loss of market share/sales
Heavy R&D investments are
needed but can way on
margins

12
1.6 Competitiors:

GE Healthcare

GE Healthcare expertise in medical imaging and information technologies, medical diagnostics,

patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies,
performance improvement and performance solutions services help our customers to deliver better
care to more people around the world at a lower cost. In addition, GE partner with healthcare
leaders, striving to leverage the global policy change necessary to implement a successful shift to
sustainable healthcare systems.
VISION, for the future invites the world to join us on our journey as we continuously develop
innovations focused on reducing costs, increasing access and improving quality around the world.

Headquartered in Chicago, IL, GE Healthcare is a unit of General Electric Company (NYSE: GE).
Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their
patients in more than 100 countries.
.

Royal Philips

Royal Philips is a diversified technology company, focused on improving peoples lives through
meaningful innovation. Royal Philips health care business makes up 42% of our global sales revenue.

With a century of history and more than 450 innovative products and services, Royal Philips is ready
to meet todays challenges in healthcare by creating solutions that deliver better care to more people
at lower cost.

Their more than 37,000 employees, working in 100 countries, are committed to helping you create
meaningful moments of care, whether in the hospital room, the living room or the boardroom. See
how we are working to create a healthier future together.

1.7 Customer Analysis:

Customers are Hospitals and Clinics. Hospitals are categorized by University Hospital, Public Hospital
and Private Hospitals.
Public Hospitals provide medical care free of charge. So their medical device procurements set basis
on lower prices. If you can offer lower and long-term payment you have advantage.
University Hospitals are institutions of training and research. Technological differentiation is the key
determination factor for sale. If your product and you offer different technology and applications that
university hospital can research and can train student so you can get advantage. Then, surely, lower
price and long term payment options are preferable.
Private Hospitals and clinics are the customer who are oriented on their customers (patient).
Generally, the important factors are price and performance of the device. If they can do daily activities
without a factor gives delay or cancel that satisfies them. So technical support and service is important.
Lower price and long term payment options are preferable, also.

13
2. Marketing Strategy

2.1 Segmentation and Targeting

2.1.1 Segmentation:

Every market consists of groups (segments) of customers with different needs and wants. Normally
no company tries to sell to everyone and that is why it has to find its targeted groups of customers
and find as much information about them as possible.

The global medical equipment market has been segmented on the basis of product type, technology,
and geography. Most medical devices can be classified by finding the matching description of the
device in Title 21 of the Code of Federal Regulations (CFR), Parts 862-892. FDA has classified and
described over 1,700 distinct types of devices and organized them in the CFR into 16 medical specialty
"panels" such as Cardiovascular devices or Ear, Nose, and Throat devices. These panels are found in
Parts 862 through 892 in the CFR. For each of the devices classified by the FDA the CFR gives a
general description including the intended use, the class to which the device belongs (i.e., Class I, II,
or III), and information about marketing requirements. Your device should meet the definition in a
classification regulation contained in 21 CFR 862-892. The five major categories of imaging
equipment studied in this report include X-ray, ultrasound, computed tomography (CT), magnetic
resonance imaging (MRI) and nuclear imaging equipment. The market for each of these equipment
has been analyzed on the basis of product types and technology. Market revenue in terms of USD
million for the period between 2013 and 2023 along with the compound annual growth rate (CAGR
%) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year.

The market overview section of this report explores market dynamics such as drivers, restraints, and
opportunities that have strong impact on the medical imaging equipment market currently and could
influence the market in future as well. The market attractiveness analysis has been provided in the
market overview section in order to explain the intensity of competition in the market in different
geographies. Porters five forces analysis is also explained in this section to understand the medical
imaging equipment market considering different parameters that have an impact on the sustainability
of the companies operating in the medical imaging equipment market. The competitive scenario
between different market players is evaluated through market share analysis in the competitive
landscape section of the report. All these factors would help the market players to take strategic
decisions in order to strengthen their positions and expand their shares in the global market.

Geographically, the medical imaging equipment market been categorized into five major regions
namely North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Market revenue in
terms of USD million for the period between 2013 and 2023 along with the CAGR % from 2015 to
2023 are provided for all the regions, considering 2014 as the base year. Each geography market is
further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany,
China, Japan, Brazil, and GCC countries. The recommendations section included in the report would

14
assist existing market players in expanding their market share and new companies in establishing their
presence in the global medical imaging equipment market.

The global medical imaging equipment market is segmented into the following categories:

Medical Imaging Equipment Market, by Product

o X-Ray Devices
Stationary
Portable
o Ultrasound Systems
Cart/Trolley Based Ultrasound System
Compact/Portable Ultrasound System
o Computed Tomography (CT) Scanners
Stationary
Mobile
o Magnetic Resonance Imaging (MRI) Equipment
Closed
Open
o Nuclear Imaging Equipment
SPECT Scanner
PET Scanner

Medical Imaging Equipment Market, by Technology

o X-Ray Devices
Analog X-ray Technology
Digital Radiography
Computed Radiography
o Ultrasound Systems
2-D
3-D & 4-D
Doppler
High Intensity Frequency Ultrasound (HIFU)
Lithotripsy
o Computed Tomography (CT) Scanners
Stationary
Mobile
o Magnetic Resonance Imaging (MRI) Equipment
Low-Slice

15
 Medium-Slice
High-Slice
o Nuclear Imaging Equipment
SPECT Scanner
PET Scanner

Medical Imaging Equipment Market, by Geography

North America
o U.S.
o Canada
Europe
o UK
o Germany
o Rest of Europe
Asia Pacific
o China
o Japan
o Rest of Asia Pacific
Latin America
o Brazil
o Rest of Latin America
Middle East and Africa (MEA)
o GCC Countries
o Rest of MEA

2.1.2 Targeting:

Siemens Healthineers Medical Systems targeting is in the fields of radiotherapy, radiosurgery, X-ray
tube technology, digital image detectors, cargo screening, and non-destructive testing depending
on strenghtness of company portfolio and all around the world except countries have embargo or
war threats.
2.2 Positioning Statements

Mission and Values

Siemens Healthineers wants to make healthcare providers succeed in an ever-changing healthcare
industry by helping them deliver better outcomes at lower costs. This purpose drives our focus: to
lead the transformation of healthcare together with the ones delivering it. In healthcare, change is
rapid and ongoing, and we understand the challenges and pressures that come along with it. Check
out our perspectives and learn more about consolidation, industrialization, and managing health

16
 Our Values Are:
o Customers First
We put customers first. Our customers trust us to deliver solutions, products, service, and performance
that enable them to do vital work for people.

o Partners for life

We are united by purpose to help save lives. We collaborate with one another and our customers to
make patient care and imaging solutions more effective, affordable, and accessible everywhere. We
serve within all parts of the world with equal care we are a multi-domestic company.

o Inspired Innovation
We turn great ideas into practical realities. We have always been inspired and energized by the
challenge of finding new and better ways to do things. Innovation drives our success.

o Doing Well by Doing the Right Thing

We grow our business while acting with integrity. Each of us is responsible for meeting the highest
standards of ethics, quality, and safety. We care for our customers, our colleagues, and our
communities.

3. Marketing Tactics

The Company's marketing tactics is based on mission and values. The strategy will be determined in
the light of the marketing mix as follows.

3.1 Marketing Mix

3.1.1 Product

Product portfolio is giving too much options for customer needs.

Company product features and price in the context of evaluating products and competing products
that create a positioning map was made as follows.

PET/CT Products

17
CT Products

MRI Products

18
3.1.1.1 Existing Products

Existing Products portfolio is at appendices.

3.1.1.2 New Product

The largest potential of the company will be the new product PET/MR system therefore the future is
evaluated in the strategy through market research will do the marketing plan within the scope of the
results.

3.1.2 Pricing

Company acts with products based on the principle of variable pricing. Implementing pricing policies
differ according to the purchasing conditions. After a detailed study on the cost price according to
the purchase and competition situation, determining the price depending on the product life cycle
will be delivered to the customer.

Under the difficult competition conditions, training which was developed by the R&D team, options
such as support information systems into putting quotes free of charge, will aim to stand out from
the competition with differentiation strategy.

Marketing PET/MR at the beginning of the product life cycle, price will be set without applying
competitive pricing policy.

19
3.1.3 Place

Company products to be sold with very fast line setup and delivery operations will be used for product
distribution channels is work that requires expertise. But the company's after-sales technical support
for customers in hand because it is important for technical service delivery plan has been prepared
and system failures occur in established service network that can intervene at least 3 hours. The new
strategy will be the same in sales will be realized.

3.1.4 Promotion

In this sector, which is experiencing intense competition and technology changes so fast promotion
activities are important. The marketing of existing products and the company will carry out promotion
activities for individual brands will represent new.

3.1.4.1 Promotion for Existing Products

Advertisement

Industry magazines and periodicals for informational purposes related to the product innovations will
be carried out each year advertising news.

Congress Participation

The participation of all professionals in the sector and alternately held each year "molecular imaging"
and "radiology and nuclear medicine" will be participating in the congress. Two congresses for the
field of audience and participants vary; Congress made detailed plans before each congress, which
will be featured on the characteristics of the products planned to be held during such promotions
will be held within budget. Each year, there are cancer congresses in Europe and America. Key
customers will be invited and display the new product(s) will be brought to this convention.

Social media

Facebook and LinkedIn page to be used actively and will be published informative videos and
information cards regularly.

In addition, customer birthdays of all members of the Facebook group to celebrate, the celebration
will be held with graphics will be designed for special occasions and holidays.

Website

Company website will be redesigned considering the future of the new product(s). Very detailed
technical information about the product will not be given through the site via the contact form to
reach the company sales staff will be provided.

On the Web site, all announcements and disclosures will be carried out via other social media
channels.

Customers will be given in reference to the website and will be regularly updated.

A web page will be published related with cancer and it will publish scientific articles on other sites
under the name of a secret marketing management and announced by the superior side of the
system and will continue to keep the channels active.

20
 Training Activities

Company products under the strategy of increased demand by expanding the use of, a training
center will be established for the implementation of software testing and training will be organized
training programs at various times.

3.1.4.2 Promotion For New Products

Advertisement

For the industry to enter a new, at least twice during two years in all the magazines accepted in the
industry followed by the company to the forefront of professional remover especially advertising
works will be carried out.

Congress Participation

Detailed research about the congress will be held at a major industry conference that most exhibitors
will be brought to the fore and organizations to do the necessary materials for the promotion of the
distribution will be held.

Social media

Company will be carried out through social media accounts as well as to be informed about new
products and existing users to search for new participants.

Website

Company website will be constantly kept up to date on upcoming products and brands. At the same
time we see under the domain name associated with PET/MR exam techniques, and detailed
information about the product site will be created.

4. Appendices
4.1 Existing Products

Siemens Healthineers offers a wide range of advanced molecular imaging systems that provide
precise exam, personalized patient care, and clinical efficiencies. Siemens Healthineers treatment
delivery systems are engineered to be easily customized, integrated and upgraded as your clinical
needs grow protecting your investment for the long run.
Biograph mCT Flow
Powered by Siemens revolutionary FlowMotion technology, Biograph mCT Flow1 is the worlds
first PET/CT system to eliminate the demand for stop-and-go imaging.

21
Biograph TruePoint PET/CT
Siemens Biograph TruePoint PET/CT is a flexible, high-powered medical imaging platform. This
innovative system optimizes clinical throughput and increases sensitivity and resolution with LSO-
based detectors but is designed with budget in mind to make PET/CT a viable solution for your
growing clinical practice.

Biograph RT Pro edition

BiographTM RT Pro edition is a comprehensive solution tailored for radiation treatment planning,
providing clinicians the right image for the right plan. Biograph RT Pro edition offers reproducible
patient positioning between the Biograph mCT family's TG-66 compliant patient handling system and
the linear accelerator couchtop, full suite of motion management technologies and a comprehensive
metal artifact solution, thus allowing clinicians to devise treatment strategies with confidence.

SOMATOM Force CT Scanner

Get two steps ahead in Preventive Care with kidney-friendly scanning and low dose early detection.
Get two steps ahead in Freezing Motion with "free-breathing" CT imaging and the industry's fastest,
most versatile scan mode.

22
SOMATOM Definition Edge CT Scanner

Confronted with increasingly complex clinical requirements and rising numbers of patients, medical
institutions are expected to perform at the limits of capacity every day. The new SOMATOM
Definition Edge helps you not only meet, but exceed these expectations by improving your
institutions process efficiency and patient outcome in all clinical capabilities from contrast media-
efficient TAVI planning to precise therapy response management, from low dose therapy control to
optimized emergency care workflow.

MAGNETOM Aera MRI

Healthcare providers worldwide are under increasing pressure to manage two contradictory forces:
delivering highest-quality care with ever decreasing financial means. The number of MRI scans
continues to rise, as MRI continues to prove its diagnostic value and expands growing clinical fields.
At the same time, global reimbursements continue to fall. MAGNETOM Aera is 1.5T MRI designed to
turn these challenges into opportunities.

MAGNETOM Skyra MRI

Healthcare providers worldwide are under increasing pressure to manage two contradictory forces:
delivering highest-quality care with ever decreasing financial means. The number of MRI scans
continues to rise, as MRI continues to prove its diagnostic value and expands growing clinical
fields1. At the same time, global reimbursements continue to fall. MAGNETOM Skyra is 3T MRI
designed to turn these challenges into opportunities.

23
5. References

www.healthcare.siemens.com
www.gehealthcare.com
www.philips.com.tr/healthcare
www.tipgorder.org.tr
www.noroloji.org.tr
www.fda.gov
www.kanser.gov.tr
www.saglik.gov.tr

24